These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 5125071)

  • 1. [On the therapeutic use of amantadine hydrochloride in non-parkinsonian hyperkinetic syndromes].
    Borromei A
    Minerva Med; 1971 Oct; 62(82):4024-6. PubMed ID: 5125071
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic effect of sulpiride in some hyperkinetic syndromes].
    Passeri S; Lisi P; Lisi R; Romagna R; Trabattoni R; Zampollo A
    Ateneo Parmense Acta Biomed; 1974; 45(4-5):299-304. PubMed ID: 4451581
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical and electroencephalographic observations on the action of amantadine in the dystonic-athetosic disorders of infentile cerebral paralysis].
    Lorizio A; Ecari U
    Minerva Med; 1971 Oct; 62(82):4036-9. PubMed ID: 5125074
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hyperkinetic syndromes. Therapeutic trials].
    Severini P; Pompili A; Pierini G
    Riv Neurol; 1978; 48(2):242-8. PubMed ID: 276041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in the electroencephalogram during treatment with amantadine].
    Ferro-Milone F; Parisen-Toldin P
    Minerva Med; 1971 Oct; 62(82):4004-6. PubMed ID: 5125064
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diseases of the extrapyramidal tracts--chorea, athetosis and others (excluding parkinsonism)].
    Watanabe H
    Naika; 1970 Jun; 25(6):1305-8. PubMed ID: 5431295
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experience with the use of midantan for treatment and prevention of the neuroleptic syndrome].
    Kamianov IM; Kupisk AG; Katsen IZ
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(8):1218-23. PubMed ID: 4149581
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of haloperidol in the treatment of extrapyramidal compulsive movement].
    Kivalo E; Weckman N
    Nervenarzt; 1970 Nov; 41(11):567-9. PubMed ID: 4249744
    [No Abstract]   [Full Text] [Related]  

  • 9. Tetrabenazine in the treatment of hyperkinetic movement disorders.
    Jankovic J
    Adv Neurol; 1983; 37():277-89. PubMed ID: 6574695
    [No Abstract]   [Full Text] [Related]  

  • 10. A controlled study of the clinical effects of amantadine hydrochloride (Symmetrel).
    Merrick EM; Schmitt PP
    Curr Ther Res Clin Exp; 1973 Aug; 15(8):552-8. PubMed ID: 4200529
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of extrapyramidal hyperkineses in childhood with tiapride].
    Klepel H; Gebelt H; Koch RD; Tzenow H
    Psychiatr Neurol Med Psychol (Leipz); 1988 Sep; 40(9):516-22. PubMed ID: 3070595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical study of amantadine in extrapyramidal syndromes caused by neuroleptics].
    Nardini M; Fanali A; Sorgonà F; Vergnano M; Fieschi G
    Minerva Med; 1971 Oct; 62(82):4020-3. PubMed ID: 5125070
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic use of tetrabenazine].
    López Del Val LJ; López-García E; Martínez-Martínez L; Santos-Lasaosa S
    Rev Neurol; 2009 May 16-31; 48(10):523-33. PubMed ID: 19434587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of tardive dyskinesias and drug-induced Parkinsonism.
    N Engl J Med; 1971 Jun; 284(24):1382-4. PubMed ID: 5576464
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experiences with memantine in the treatment of severe spastic and extrapyramidal movement disorders in combination with stereotaxic surgery].
    Mundinger F; Milios E
    Nervenarzt; 1985 Feb; 56(2):106-9. PubMed ID: 3885059
    [No Abstract]   [Full Text] [Related]  

  • 16. [Action of amantadine in extrapyramidal syndromes caused by neuroleptics].
    Fanali A; Nardini M; Sorgona F
    Sist Nerv; 1970; 22(5):273-85. PubMed ID: 5514245
    [No Abstract]   [Full Text] [Related]  

  • 17. [Haloperidol in the treatment of hyperkinetic syndromes].
    Kivalo E; Weckman N
    Duodecim; 1970; 86(3):129-32. PubMed ID: 5447422
    [No Abstract]   [Full Text] [Related]  

  • 18. [Recent therapeutic conquests in extrapyramidal syndromes].
    Schergna E
    Minerva Med; 1970 Dec; 61(101):5829-35. PubMed ID: 4322470
    [No Abstract]   [Full Text] [Related]  

  • 19. Involuntary movements not due to parkinsonism.
    Drug Ther Bull; 1974 Oct; 12(22):85-7. PubMed ID: 4156319
    [No Abstract]   [Full Text] [Related]  

  • 20. [Results obtained with L-DOPA and amantadine in the treatment of patients with disorders of consciousness and of the vigilant state].
    Paini GP; Passoni M
    Ateneo Parmense Acta Biomed; 1973 Sep; 44(5):353-9. PubMed ID: 4794006
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.